Global Angiopoietin 2 Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Angiopoietin 2 market size was valued at US$ million in 2023. With growing demand in downstream market, the Angiopoietin 2 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Angiopoietin 2 market. Angiopoietin 2 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Angiopoietin 2. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Angiopoietin 2 market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Angiopoietin 2 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Angiopoietin 2 market. It may include historical data, market segmentation by Type (e.g., Atu-111, BI-836880), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Angiopoietin 2 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Angiopoietin 2 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Angiopoietin 2 industry. This include advancements in Angiopoietin 2 technology, Angiopoietin 2 new entrants, Angiopoietin 2 new investment, and other innovations that are shaping the future of Angiopoietin 2.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Angiopoietin 2 market. It includes factors influencing customer ' purchasing decisions, preferences for Angiopoietin 2 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Angiopoietin 2 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Angiopoietin 2 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Angiopoietin 2 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Angiopoietin 2 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Angiopoietin 2 market.
Market Segmentation:
Angiopoietin 2 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Angiopoietin 2 market?
What factors are driving Angiopoietin 2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Angiopoietin 2 market opportunities vary by end market size?
How does Angiopoietin 2 break out type, application?
According to our LPI (LP Information) latest study, the global Angiopoietin 2 market size was valued at US$ million in 2023. With growing demand in downstream market, the Angiopoietin 2 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Angiopoietin 2 market. Angiopoietin 2 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Angiopoietin 2. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Angiopoietin 2 market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Angiopoietin 2 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Angiopoietin 2 market. It may include historical data, market segmentation by Type (e.g., Atu-111, BI-836880), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Angiopoietin 2 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Angiopoietin 2 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Angiopoietin 2 industry. This include advancements in Angiopoietin 2 technology, Angiopoietin 2 new entrants, Angiopoietin 2 new investment, and other innovations that are shaping the future of Angiopoietin 2.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Angiopoietin 2 market. It includes factors influencing customer ' purchasing decisions, preferences for Angiopoietin 2 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Angiopoietin 2 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Angiopoietin 2 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Angiopoietin 2 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Angiopoietin 2 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Angiopoietin 2 market.
Market Segmentation:
Angiopoietin 2 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Atu-111
- BI-836880
- LY-3127804
- MEDI-3617
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- AnGes MG, Inc.
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- MedImmune, LLC
- Regeneron Pharmaceuticals, Inc.
- RXi Pharmaceuticals Corporation
- Silence Therapeutics Plc
- Synergys Biotherapeutics, Inc.
What is the 10-year outlook for the global Angiopoietin 2 market?
What factors are driving Angiopoietin 2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Angiopoietin 2 market opportunities vary by end market size?
How does Angiopoietin 2 break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angiopoietin 2 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Angiopoietin 2 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Angiopoietin 2 by Country/Region, 2019, 2023 & 2030
2.2 Angiopoietin 2 Segment by Type
2.2.1 Atu-111
2.2.2 BI-836880
2.2.3 LY-3127804
2.2.4 MEDI-3617
2.2.5 Others
2.3 Angiopoietin 2 Sales by Type
2.3.1 Global Angiopoietin 2 Sales Market Share by Type (2019-2024)
2.3.2 Global Angiopoietin 2 Revenue and Market Share by Type (2019-2024)
2.3.3 Global Angiopoietin 2 Sale Price by Type (2019-2024)
2.4 Angiopoietin 2 Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Angiopoietin 2 Sales by Application
2.5.1 Global Angiopoietin 2 Sale Market Share by Application (2019-2024)
2.5.2 Global Angiopoietin 2 Revenue and Market Share by Application (2019-2024)
2.5.3 Global Angiopoietin 2 Sale Price by Application (2019-2024)
3 GLOBAL ANGIOPOIETIN 2 BY COMPANY
3.1 Global Angiopoietin 2 Breakdown Data by Company
3.1.1 Global Angiopoietin 2 Annual Sales by Company (2019-2024)
3.1.2 Global Angiopoietin 2 Sales Market Share by Company (2019-2024)
3.2 Global Angiopoietin 2 Annual Revenue by Company (2019-2024)
3.2.1 Global Angiopoietin 2 Revenue by Company (2019-2024)
3.2.2 Global Angiopoietin 2 Revenue Market Share by Company (2019-2024)
3.3 Global Angiopoietin 2 Sale Price by Company
3.4 Key Manufacturers Angiopoietin 2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiopoietin 2 Product Location Distribution
3.4.2 Players Angiopoietin 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANGIOPOIETIN 2 BY GEOGRAPHIC REGION
4.1 World Historic Angiopoietin 2 Market Size by Geographic Region (2019-2024)
4.1.1 Global Angiopoietin 2 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Angiopoietin 2 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Angiopoietin 2 Market Size by Country/Region (2019-2024)
4.2.1 Global Angiopoietin 2 Annual Sales by Country/Region (2019-2024)
4.2.2 Global Angiopoietin 2 Annual Revenue by Country/Region (2019-2024)
4.3 Americas Angiopoietin 2 Sales Growth
4.4 APAC Angiopoietin 2 Sales Growth
4.5 Europe Angiopoietin 2 Sales Growth
4.6 Middle East & Africa Angiopoietin 2 Sales Growth
5 AMERICAS
5.1 Americas Angiopoietin 2 Sales by Country
5.1.1 Americas Angiopoietin 2 Sales by Country (2019-2024)
5.1.2 Americas Angiopoietin 2 Revenue by Country (2019-2024)
5.2 Americas Angiopoietin 2 Sales by Type
5.3 Americas Angiopoietin 2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiopoietin 2 Sales by Region
6.1.1 APAC Angiopoietin 2 Sales by Region (2019-2024)
6.1.2 APAC Angiopoietin 2 Revenue by Region (2019-2024)
6.2 APAC Angiopoietin 2 Sales by Type
6.3 APAC Angiopoietin 2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Angiopoietin 2 by Country
7.1.1 Europe Angiopoietin 2 Sales by Country (2019-2024)
7.1.2 Europe Angiopoietin 2 Revenue by Country (2019-2024)
7.2 Europe Angiopoietin 2 Sales by Type
7.3 Europe Angiopoietin 2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angiopoietin 2 by Country
8.1.1 Middle East & Africa Angiopoietin 2 Sales by Country (2019-2024)
8.1.2 Middle East & Africa Angiopoietin 2 Revenue by Country (2019-2024)
8.2 Middle East & Africa Angiopoietin 2 Sales by Type
8.3 Middle East & Africa Angiopoietin 2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiopoietin
10.3 Manufacturing Process Analysis of Angiopoietin
10.4 Industry Chain Structure of Angiopoietin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiopoietin 2 Distributors
11.3 Angiopoietin 2 Customer
12 WORLD FORECAST REVIEW FOR ANGIOPOIETIN 2 BY GEOGRAPHIC REGION
12.1 Global Angiopoietin 2 Market Size Forecast by Region
12.1.1 Global Angiopoietin 2 Forecast by Region (2025-2030)
12.1.2 Global Angiopoietin 2 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiopoietin 2 Forecast by Type
12.7 Global Angiopoietin 2 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Angiopoietin 2 Product Portfolios and Specifications
13.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 AnGes MG, Inc.
13.2.1 AnGes MG, Inc. Company Information
13.2.2 AnGes MG, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AnGes MG, Inc. Main Business Overview
13.2.5 AnGes MG, Inc. Latest Developments
13.3 Boehringer Ingelheim GmbH
13.3.1 Boehringer Ingelheim GmbH Company Information
13.3.2 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim GmbH Main Business Overview
13.3.5 Boehringer Ingelheim GmbH Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Angiopoietin 2 Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Information
13.5.2 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolios and Specifications
13.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.6 MedImmune, LLC
13.6.1 MedImmune, LLC Company Information
13.6.2 MedImmune, LLC Angiopoietin 2 Product Portfolios and Specifications
13.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MedImmune, LLC Main Business Overview
13.6.5 MedImmune, LLC Latest Developments
13.7 Regeneron Pharmaceuticals, Inc.
13.7.1 Regeneron Pharmaceuticals, Inc. Company Information
13.7.2 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Regeneron Pharmaceuticals, Inc. Main Business Overview
13.7.5 Regeneron Pharmaceuticals, Inc. Latest Developments
13.8 RXi Pharmaceuticals Corporation
13.8.1 RXi Pharmaceuticals Corporation Company Information
13.8.2 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolios and Specifications
13.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 RXi Pharmaceuticals Corporation Main Business Overview
13.8.5 RXi Pharmaceuticals Corporation Latest Developments
13.9 Silence Therapeutics Plc
13.9.1 Silence Therapeutics Plc Company Information
13.9.2 Silence Therapeutics Plc Angiopoietin 2 Product Portfolios and Specifications
13.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Silence Therapeutics Plc Main Business Overview
13.9.5 Silence Therapeutics Plc Latest Developments
13.10 Synergys Biotherapeutics, Inc.
13.10.1 Synergys Biotherapeutics, Inc. Company Information
13.10.2 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synergys Biotherapeutics, Inc. Main Business Overview
13.10.5 Synergys Biotherapeutics, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Angiopoietin 2 Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Angiopoietin 2 by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Angiopoietin 2 by Country/Region, 2019, 2023 & 2030
2.2 Angiopoietin 2 Segment by Type
2.2.1 Atu-111
2.2.2 BI-836880
2.2.3 LY-3127804
2.2.4 MEDI-3617
2.2.5 Others
2.3 Angiopoietin 2 Sales by Type
2.3.1 Global Angiopoietin 2 Sales Market Share by Type (2019-2024)
2.3.2 Global Angiopoietin 2 Revenue and Market Share by Type (2019-2024)
2.3.3 Global Angiopoietin 2 Sale Price by Type (2019-2024)
2.4 Angiopoietin 2 Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Angiopoietin 2 Sales by Application
2.5.1 Global Angiopoietin 2 Sale Market Share by Application (2019-2024)
2.5.2 Global Angiopoietin 2 Revenue and Market Share by Application (2019-2024)
2.5.3 Global Angiopoietin 2 Sale Price by Application (2019-2024)
3 GLOBAL ANGIOPOIETIN 2 BY COMPANY
3.1 Global Angiopoietin 2 Breakdown Data by Company
3.1.1 Global Angiopoietin 2 Annual Sales by Company (2019-2024)
3.1.2 Global Angiopoietin 2 Sales Market Share by Company (2019-2024)
3.2 Global Angiopoietin 2 Annual Revenue by Company (2019-2024)
3.2.1 Global Angiopoietin 2 Revenue by Company (2019-2024)
3.2.2 Global Angiopoietin 2 Revenue Market Share by Company (2019-2024)
3.3 Global Angiopoietin 2 Sale Price by Company
3.4 Key Manufacturers Angiopoietin 2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Angiopoietin 2 Product Location Distribution
3.4.2 Players Angiopoietin 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANGIOPOIETIN 2 BY GEOGRAPHIC REGION
4.1 World Historic Angiopoietin 2 Market Size by Geographic Region (2019-2024)
4.1.1 Global Angiopoietin 2 Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Angiopoietin 2 Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Angiopoietin 2 Market Size by Country/Region (2019-2024)
4.2.1 Global Angiopoietin 2 Annual Sales by Country/Region (2019-2024)
4.2.2 Global Angiopoietin 2 Annual Revenue by Country/Region (2019-2024)
4.3 Americas Angiopoietin 2 Sales Growth
4.4 APAC Angiopoietin 2 Sales Growth
4.5 Europe Angiopoietin 2 Sales Growth
4.6 Middle East & Africa Angiopoietin 2 Sales Growth
5 AMERICAS
5.1 Americas Angiopoietin 2 Sales by Country
5.1.1 Americas Angiopoietin 2 Sales by Country (2019-2024)
5.1.2 Americas Angiopoietin 2 Revenue by Country (2019-2024)
5.2 Americas Angiopoietin 2 Sales by Type
5.3 Americas Angiopoietin 2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiopoietin 2 Sales by Region
6.1.1 APAC Angiopoietin 2 Sales by Region (2019-2024)
6.1.2 APAC Angiopoietin 2 Revenue by Region (2019-2024)
6.2 APAC Angiopoietin 2 Sales by Type
6.3 APAC Angiopoietin 2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Angiopoietin 2 by Country
7.1.1 Europe Angiopoietin 2 Sales by Country (2019-2024)
7.1.2 Europe Angiopoietin 2 Revenue by Country (2019-2024)
7.2 Europe Angiopoietin 2 Sales by Type
7.3 Europe Angiopoietin 2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Angiopoietin 2 by Country
8.1.1 Middle East & Africa Angiopoietin 2 Sales by Country (2019-2024)
8.1.2 Middle East & Africa Angiopoietin 2 Revenue by Country (2019-2024)
8.2 Middle East & Africa Angiopoietin 2 Sales by Type
8.3 Middle East & Africa Angiopoietin 2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Angiopoietin
10.3 Manufacturing Process Analysis of Angiopoietin
10.4 Industry Chain Structure of Angiopoietin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Angiopoietin 2 Distributors
11.3 Angiopoietin 2 Customer
12 WORLD FORECAST REVIEW FOR ANGIOPOIETIN 2 BY GEOGRAPHIC REGION
12.1 Global Angiopoietin 2 Market Size Forecast by Region
12.1.1 Global Angiopoietin 2 Forecast by Region (2025-2030)
12.1.2 Global Angiopoietin 2 Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Angiopoietin 2 Forecast by Type
12.7 Global Angiopoietin 2 Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Angiopoietin 2 Product Portfolios and Specifications
13.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 AnGes MG, Inc.
13.2.1 AnGes MG, Inc. Company Information
13.2.2 AnGes MG, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AnGes MG, Inc. Main Business Overview
13.2.5 AnGes MG, Inc. Latest Developments
13.3 Boehringer Ingelheim GmbH
13.3.1 Boehringer Ingelheim GmbH Company Information
13.3.2 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Boehringer Ingelheim GmbH Main Business Overview
13.3.5 Boehringer Ingelheim GmbH Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Angiopoietin 2 Product Portfolios and Specifications
13.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Information
13.5.2 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolios and Specifications
13.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.6 MedImmune, LLC
13.6.1 MedImmune, LLC Company Information
13.6.2 MedImmune, LLC Angiopoietin 2 Product Portfolios and Specifications
13.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MedImmune, LLC Main Business Overview
13.6.5 MedImmune, LLC Latest Developments
13.7 Regeneron Pharmaceuticals, Inc.
13.7.1 Regeneron Pharmaceuticals, Inc. Company Information
13.7.2 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Regeneron Pharmaceuticals, Inc. Main Business Overview
13.7.5 Regeneron Pharmaceuticals, Inc. Latest Developments
13.8 RXi Pharmaceuticals Corporation
13.8.1 RXi Pharmaceuticals Corporation Company Information
13.8.2 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolios and Specifications
13.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 RXi Pharmaceuticals Corporation Main Business Overview
13.8.5 RXi Pharmaceuticals Corporation Latest Developments
13.9 Silence Therapeutics Plc
13.9.1 Silence Therapeutics Plc Company Information
13.9.2 Silence Therapeutics Plc Angiopoietin 2 Product Portfolios and Specifications
13.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Silence Therapeutics Plc Main Business Overview
13.9.5 Silence Therapeutics Plc Latest Developments
13.10 Synergys Biotherapeutics, Inc.
13.10.1 Synergys Biotherapeutics, Inc. Company Information
13.10.2 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolios and Specifications
13.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synergys Biotherapeutics, Inc. Main Business Overview
13.10.5 Synergys Biotherapeutics, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Angiopoietin 2 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Angiopoietin 2 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Atu-111
Table 4. Major Players of BI-836880
Table 5. Major Players of LY-3127804
Table 6. Major Players of MEDI-3617
Table 7. Major Players of Others
Table 8. Global Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 9. Global Angiopoietin 2 Sales Market Share by Type (2019-2024)
Table 10. Global Angiopoietin 2 Revenue by Type (2019-2024) & ($ million)
Table 11. Global Angiopoietin 2 Revenue Market Share by Type (2019-2024)
Table 12. Global Angiopoietin 2 Sale Price by Type (2019-2024) & (USD/Pcs)
Table 13. Global Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 14. Global Angiopoietin 2 Sales Market Share by Application (2019-2024)
Table 15. Global Angiopoietin 2 Revenue by Application (2019-2024)
Table 16. Global Angiopoietin 2 Revenue Market Share by Application (2019-2024)
Table 17. Global Angiopoietin 2 Sale Price by Application (2019-2024) & (USD/Pcs)
Table 18. Global Angiopoietin 2 Sales by Company (2019-2024) & (K Pcs)
Table 19. Global Angiopoietin 2 Sales Market Share by Company (2019-2024)
Table 20. Global Angiopoietin 2 Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Angiopoietin 2 Revenue Market Share by Company (2019-2024)
Table 22. Global Angiopoietin 2 Sale Price by Company (2019-2024) & (USD/Pcs)
Table 23. Key Manufacturers Angiopoietin 2 Producing Area Distribution and Sales Area
Table 24. Players Angiopoietin 2 Products Offered
Table 25. Angiopoietin 2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Angiopoietin 2 Sales by Geographic Region (2019-2024) & (K Pcs)
Table 29. Global Angiopoietin 2 Sales Market Share Geographic Region (2019-2024)
Table 30. Global Angiopoietin 2 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Angiopoietin 2 Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Angiopoietin 2 Sales by Country/Region (2019-2024) & (K Pcs)
Table 33. Global Angiopoietin 2 Sales Market Share by Country/Region (2019-2024)
Table 34. Global Angiopoietin 2 Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Angiopoietin 2 Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 37. Americas Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 38. Americas Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 40. Americas Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 41. Americas Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 42. APAC Angiopoietin 2 Sales by Region (2019-2024) & (K Pcs)
Table 43. APAC Angiopoietin 2 Sales Market Share by Region (2019-2024)
Table 44. APAC Angiopoietin 2 Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Angiopoietin 2 Revenue Market Share by Region (2019-2024)
Table 46. APAC Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 47. APAC Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 48. Europe Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 49. Europe Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 50. Europe Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 52. Europe Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 53. Europe Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 59. Middle East & Africa Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Angiopoietin 2
Table 61. Key Market Challenges & Risks of Angiopoietin 2
Table 62. Key Industry Trends of Angiopoietin 2
Table 63. Angiopoietin 2 Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Angiopoietin 2 Distributors List
Table 66. Angiopoietin 2 Customer List
Table 67. Global Angiopoietin 2 Sales Forecast by Region (2025-2030) & (K Pcs)
Table 68. Global Angiopoietin 2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 70. Americas Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Angiopoietin 2 Sales Forecast by Region (2025-2030) & (K Pcs)
Table 72. APAC Angiopoietin 2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 74. Europe Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 76. Middle East & Africa Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Angiopoietin 2 Sales Forecast by Type (2025-2030) & (K Pcs)
Table 78. Global Angiopoietin 2 Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Angiopoietin 2 Sales Forecast by Application (2025-2030) & (K Pcs)
Table 80. Global Angiopoietin 2 Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Amgen Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 82. Amgen Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 83. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 84. Amgen Inc. Main Business
Table 85. Amgen Inc. Latest Developments
Table 86. AnGes MG, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 87. AnGes MG, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 88. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 89. AnGes MG, Inc. Main Business
Table 90. AnGes MG, Inc. Latest Developments
Table 91. Boehringer Ingelheim GmbH Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 92. Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolios and Specifications
Table 93. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 94. Boehringer Ingelheim GmbH Main Business
Table 95. Boehringer Ingelheim GmbH Latest Developments
Table 96. Eli Lilly and Company Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 97. Eli Lilly and Company Angiopoietin 2 Product Portfolios and Specifications
Table 98. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 99. Eli Lilly and Company Main Business
Table 100. Eli Lilly and Company Latest Developments
Table 101. F. Hoffmann-La Roche Ltd. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 102. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolios and Specifications
Table 103. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 104. F. Hoffmann-La Roche Ltd. Main Business
Table 105. F. Hoffmann-La Roche Ltd. Latest Developments
Table 106. MedImmune, LLC Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 107. MedImmune, LLC Angiopoietin 2 Product Portfolios and Specifications
Table 108. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 109. MedImmune, LLC Main Business
Table 110. MedImmune, LLC Latest Developments
Table 111. Regeneron Pharmaceuticals, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 113. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 114. Regeneron Pharmaceuticals, Inc. Main Business
Table 115. Regeneron Pharmaceuticals, Inc. Latest Developments
Table 116. RXi Pharmaceuticals Corporation Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 117. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolios and Specifications
Table 118. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 119. RXi Pharmaceuticals Corporation Main Business
Table 120. RXi Pharmaceuticals Corporation Latest Developments
Table 121. Silence Therapeutics Plc Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 122. Silence Therapeutics Plc Angiopoietin 2 Product Portfolios and Specifications
Table 123. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 124. Silence Therapeutics Plc Main Business
Table 125. Silence Therapeutics Plc Latest Developments
Table 126. Synergys Biotherapeutics, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 127. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 128. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 129. Synergys Biotherapeutics, Inc. Main Business
Table 130. Synergys Biotherapeutics, Inc. Latest Developments
Table 1. Angiopoietin 2 Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Angiopoietin 2 Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Atu-111
Table 4. Major Players of BI-836880
Table 5. Major Players of LY-3127804
Table 6. Major Players of MEDI-3617
Table 7. Major Players of Others
Table 8. Global Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 9. Global Angiopoietin 2 Sales Market Share by Type (2019-2024)
Table 10. Global Angiopoietin 2 Revenue by Type (2019-2024) & ($ million)
Table 11. Global Angiopoietin 2 Revenue Market Share by Type (2019-2024)
Table 12. Global Angiopoietin 2 Sale Price by Type (2019-2024) & (USD/Pcs)
Table 13. Global Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 14. Global Angiopoietin 2 Sales Market Share by Application (2019-2024)
Table 15. Global Angiopoietin 2 Revenue by Application (2019-2024)
Table 16. Global Angiopoietin 2 Revenue Market Share by Application (2019-2024)
Table 17. Global Angiopoietin 2 Sale Price by Application (2019-2024) & (USD/Pcs)
Table 18. Global Angiopoietin 2 Sales by Company (2019-2024) & (K Pcs)
Table 19. Global Angiopoietin 2 Sales Market Share by Company (2019-2024)
Table 20. Global Angiopoietin 2 Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Angiopoietin 2 Revenue Market Share by Company (2019-2024)
Table 22. Global Angiopoietin 2 Sale Price by Company (2019-2024) & (USD/Pcs)
Table 23. Key Manufacturers Angiopoietin 2 Producing Area Distribution and Sales Area
Table 24. Players Angiopoietin 2 Products Offered
Table 25. Angiopoietin 2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Angiopoietin 2 Sales by Geographic Region (2019-2024) & (K Pcs)
Table 29. Global Angiopoietin 2 Sales Market Share Geographic Region (2019-2024)
Table 30. Global Angiopoietin 2 Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Angiopoietin 2 Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Angiopoietin 2 Sales by Country/Region (2019-2024) & (K Pcs)
Table 33. Global Angiopoietin 2 Sales Market Share by Country/Region (2019-2024)
Table 34. Global Angiopoietin 2 Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Angiopoietin 2 Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 37. Americas Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 38. Americas Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 40. Americas Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 41. Americas Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 42. APAC Angiopoietin 2 Sales by Region (2019-2024) & (K Pcs)
Table 43. APAC Angiopoietin 2 Sales Market Share by Region (2019-2024)
Table 44. APAC Angiopoietin 2 Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Angiopoietin 2 Revenue Market Share by Region (2019-2024)
Table 46. APAC Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 47. APAC Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 48. Europe Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 49. Europe Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 50. Europe Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 52. Europe Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 53. Europe Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 54. Middle East & Africa Angiopoietin 2 Sales by Country (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Angiopoietin 2 Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Angiopoietin 2 Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Angiopoietin 2 Sales by Type (2019-2024) & (K Pcs)
Table 59. Middle East & Africa Angiopoietin 2 Sales by Application (2019-2024) & (K Pcs)
Table 60. Key Market Drivers & Growth Opportunities of Angiopoietin 2
Table 61. Key Market Challenges & Risks of Angiopoietin 2
Table 62. Key Industry Trends of Angiopoietin 2
Table 63. Angiopoietin 2 Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Angiopoietin 2 Distributors List
Table 66. Angiopoietin 2 Customer List
Table 67. Global Angiopoietin 2 Sales Forecast by Region (2025-2030) & (K Pcs)
Table 68. Global Angiopoietin 2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 70. Americas Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Angiopoietin 2 Sales Forecast by Region (2025-2030) & (K Pcs)
Table 72. APAC Angiopoietin 2 Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 74. Europe Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Angiopoietin 2 Sales Forecast by Country (2025-2030) & (K Pcs)
Table 76. Middle East & Africa Angiopoietin 2 Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Angiopoietin 2 Sales Forecast by Type (2025-2030) & (K Pcs)
Table 78. Global Angiopoietin 2 Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Angiopoietin 2 Sales Forecast by Application (2025-2030) & (K Pcs)
Table 80. Global Angiopoietin 2 Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Amgen Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 82. Amgen Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 83. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 84. Amgen Inc. Main Business
Table 85. Amgen Inc. Latest Developments
Table 86. AnGes MG, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 87. AnGes MG, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 88. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 89. AnGes MG, Inc. Main Business
Table 90. AnGes MG, Inc. Latest Developments
Table 91. Boehringer Ingelheim GmbH Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 92. Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolios and Specifications
Table 93. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 94. Boehringer Ingelheim GmbH Main Business
Table 95. Boehringer Ingelheim GmbH Latest Developments
Table 96. Eli Lilly and Company Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 97. Eli Lilly and Company Angiopoietin 2 Product Portfolios and Specifications
Table 98. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 99. Eli Lilly and Company Main Business
Table 100. Eli Lilly and Company Latest Developments
Table 101. F. Hoffmann-La Roche Ltd. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 102. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolios and Specifications
Table 103. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 104. F. Hoffmann-La Roche Ltd. Main Business
Table 105. F. Hoffmann-La Roche Ltd. Latest Developments
Table 106. MedImmune, LLC Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 107. MedImmune, LLC Angiopoietin 2 Product Portfolios and Specifications
Table 108. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 109. MedImmune, LLC Main Business
Table 110. MedImmune, LLC Latest Developments
Table 111. Regeneron Pharmaceuticals, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 112. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 113. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 114. Regeneron Pharmaceuticals, Inc. Main Business
Table 115. Regeneron Pharmaceuticals, Inc. Latest Developments
Table 116. RXi Pharmaceuticals Corporation Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 117. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolios and Specifications
Table 118. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 119. RXi Pharmaceuticals Corporation Main Business
Table 120. RXi Pharmaceuticals Corporation Latest Developments
Table 121. Silence Therapeutics Plc Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 122. Silence Therapeutics Plc Angiopoietin 2 Product Portfolios and Specifications
Table 123. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 124. Silence Therapeutics Plc Main Business
Table 125. Silence Therapeutics Plc Latest Developments
Table 126. Synergys Biotherapeutics, Inc. Basic Information, Angiopoietin 2 Manufacturing Base, Sales Area and Its Competitors
Table 127. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolios and Specifications
Table 128. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 129. Synergys Biotherapeutics, Inc. Main Business
Table 130. Synergys Biotherapeutics, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Angiopoietin 2
Figure 2. Angiopoietin 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiopoietin 2 Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Angiopoietin 2 Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Angiopoietin 2 Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Atu-111
Figure 10. Product Picture of BI-836880
Figure 11. Product Picture of LY-3127804
Figure 12. Product Picture of MEDI-3617
Figure 13. Product Picture of Others
Figure 14. Global Angiopoietin 2 Sales Market Share by Type in 2023
Figure 15. Global Angiopoietin 2 Revenue Market Share by Type (2019-2024)
Figure 16. Angiopoietin 2 Consumed in Hospital
Figure 17. Global Angiopoietin 2 Market: Hospital (2019-2024) & (K Pcs)
Figure 18. Angiopoietin 2 Consumed in Clinic
Figure 19. Global Angiopoietin 2 Market: Clinic (2019-2024) & (K Pcs)
Figure 20. Angiopoietin 2 Consumed in Others
Figure 21. Global Angiopoietin 2 Market: Others (2019-2024) & (K Pcs)
Figure 22. Global Angiopoietin 2 Sales Market Share by Application (2023)
Figure 23. Global Angiopoietin 2 Revenue Market Share by Application in 2023
Figure 24. Angiopoietin 2 Sales Market by Company in 2023 (K Pcs)
Figure 25. Global Angiopoietin 2 Sales Market Share by Company in 2023
Figure 26. Angiopoietin 2 Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Angiopoietin 2 Revenue Market Share by Company in 2023
Figure 28. Global Angiopoietin 2 Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Angiopoietin 2 Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 31. Americas Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 32. APAC Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 33. APAC Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 34. Europe Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 35. Europe Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 37. Middle East & Africa Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 38. Americas Angiopoietin 2 Sales Market Share by Country in 2023
Figure 39. Americas Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 40. Americas Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 41. Americas Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 42. United States Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Angiopoietin 2 Sales Market Share by Region in 2023
Figure 47. APAC Angiopoietin 2 Revenue Market Share by Regions in 2023
Figure 48. APAC Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 49. APAC Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 50. China Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Angiopoietin 2 Sales Market Share by Country in 2023
Figure 58. Europe Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 59. Europe Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 60. Europe Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 61. Germany Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Angiopoietin 2 Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 70. Egypt Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Angiopoietin 2 in 2023
Figure 76. Manufacturing Process Analysis of Angiopoietin 2
Figure 77. Industry Chain Structure of Angiopoietin 2
Figure 78. Channels of Distribution
Figure 79. Global Angiopoietin 2 Sales Market Forecast by Region (2025-2030)
Figure 80. Global Angiopoietin 2 Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Angiopoietin 2 Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Angiopoietin 2 Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Angiopoietin 2 Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Angiopoietin 2 Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Angiopoietin 2
Figure 2. Angiopoietin 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Angiopoietin 2 Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Angiopoietin 2 Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Angiopoietin 2 Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Atu-111
Figure 10. Product Picture of BI-836880
Figure 11. Product Picture of LY-3127804
Figure 12. Product Picture of MEDI-3617
Figure 13. Product Picture of Others
Figure 14. Global Angiopoietin 2 Sales Market Share by Type in 2023
Figure 15. Global Angiopoietin 2 Revenue Market Share by Type (2019-2024)
Figure 16. Angiopoietin 2 Consumed in Hospital
Figure 17. Global Angiopoietin 2 Market: Hospital (2019-2024) & (K Pcs)
Figure 18. Angiopoietin 2 Consumed in Clinic
Figure 19. Global Angiopoietin 2 Market: Clinic (2019-2024) & (K Pcs)
Figure 20. Angiopoietin 2 Consumed in Others
Figure 21. Global Angiopoietin 2 Market: Others (2019-2024) & (K Pcs)
Figure 22. Global Angiopoietin 2 Sales Market Share by Application (2023)
Figure 23. Global Angiopoietin 2 Revenue Market Share by Application in 2023
Figure 24. Angiopoietin 2 Sales Market by Company in 2023 (K Pcs)
Figure 25. Global Angiopoietin 2 Sales Market Share by Company in 2023
Figure 26. Angiopoietin 2 Revenue Market by Company in 2023 ($ Million)
Figure 27. Global Angiopoietin 2 Revenue Market Share by Company in 2023
Figure 28. Global Angiopoietin 2 Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Angiopoietin 2 Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 31. Americas Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 32. APAC Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 33. APAC Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 34. Europe Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 35. Europe Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Angiopoietin 2 Sales 2019-2024 (K Pcs)
Figure 37. Middle East & Africa Angiopoietin 2 Revenue 2019-2024 ($ Millions)
Figure 38. Americas Angiopoietin 2 Sales Market Share by Country in 2023
Figure 39. Americas Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 40. Americas Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 41. Americas Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 42. United States Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 43. Canada Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 44. Mexico Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 45. Brazil Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 46. APAC Angiopoietin 2 Sales Market Share by Region in 2023
Figure 47. APAC Angiopoietin 2 Revenue Market Share by Regions in 2023
Figure 48. APAC Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 49. APAC Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 50. China Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 51. Japan Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 52. South Korea Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 53. Southeast Asia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 54. India Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 55. Australia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 56. China Taiwan Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 57. Europe Angiopoietin 2 Sales Market Share by Country in 2023
Figure 58. Europe Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 59. Europe Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 60. Europe Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 61. Germany Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 62. France Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 63. UK Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 64. Italy Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 65. Russia Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 66. Middle East & Africa Angiopoietin 2 Sales Market Share by Country in 2023
Figure 67. Middle East & Africa Angiopoietin 2 Revenue Market Share by Country in 2023
Figure 68. Middle East & Africa Angiopoietin 2 Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Angiopoietin 2 Sales Market Share by Application (2019-2024)
Figure 70. Egypt Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 71. South Africa Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 72. Israel Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 73. Turkey Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 74. GCC Country Angiopoietin 2 Revenue Growth 2019-2024 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Angiopoietin 2 in 2023
Figure 76. Manufacturing Process Analysis of Angiopoietin 2
Figure 77. Industry Chain Structure of Angiopoietin 2
Figure 78. Channels of Distribution
Figure 79. Global Angiopoietin 2 Sales Market Forecast by Region (2025-2030)
Figure 80. Global Angiopoietin 2 Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Angiopoietin 2 Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Angiopoietin 2 Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Angiopoietin 2 Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Angiopoietin 2 Revenue Market Share Forecast by Application (2025-2030)
